Virtual Medicinal Product (VMP)
-
Testosterone 50mg/5g transdermal gel unit dose sachets
Name Details
Current Name
Testosterone 50mg/5g transdermal gel unit dose sachets
|
Start Date
01-11-2023
|
End Date
|
Previous Name
Testosterone 50mg/5g gel unit dose sachets
|
Start Date
30-07-2015
|
End Date
31-10-2023
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- sachet
- Unit Dose UOM
- sachet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 4 (CD Anab)
- Route
- Transdermal
- Form
- Transdermal gel
- Ontology Form/Route
- gel.transdermal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G03BA03
BNF |
Current BNF
06040200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06040200
|
Start Date
24-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
9478711000001105 |
11-08-2005 |
|
4639711000001101 |
27-06-2003 |
10-08-2005 |
VMP Ingredients
VMP ingredients table
Testosterone |
Based on Ingredient Substance |
|
50 mg |
|
Name
Testosterone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Testosterone
-
VMP
(Current) Testosterone 50mg/5g transdermal gel...
Virtual Medicinal Product Pack (VMPP) Information